Financial Disclosure, Industry Sponsorship, and Integrity in Cancer Research Reporting
A partir d'une revue de la littérature sur les essais cliniques de phase III entre janvier 2008 et octobre 2011 (soit 150 essais et éditoriaux associés), cette étude analyse l'association entre les conclusions des auteurs et leurs déclarations de conflits d'intérêts
In the United States and elsewhere in the world, the pharmaceutical industry provides a substantial and an ever increasing proportion of clinical trials funding. This trend has prompted considerable anxiety in some quarters because several studies have shown that there is a clear association between pharmaceutical industry funding and proindustry results, calling into question the integrity of data reporting....
Journal of Clinical Oncology , éditorial en libre accès, 2013